Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:

Displaying 3 of 3 Results
Age
Type
Conditions or Disease:

Intermediate Expanded Access Protocol (EAP) CNMAu8.EAP02

Namita Goyal

  • OPEN TO ACCRUAL
Get More Information

Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in ALS

Namita Goyal

  • OPEN TO ACCRUAL
Get More Information